euromedica-mhs
TRANSCRIPT
-
8/21/2019 euromedica-mhs
1/373
1
Chapter I
Introduction
1.1 The Foundations and Importance of this Research
It is widely accepted that innovation has assumed great importance for organisations
in sustaining their competitiveness (e.g. Tidd et al , 2005; Bernstein & Singh, 2006;
Ussman et al , 2001; De Propris, 2002). Blumentritt et al (2005), whose study
concentrates on how entrepreneurs develop internal cultures that may inspire and impel
innovation, argue that continuous innovation requires organisational systems and
procedures that are embedded, so as to ensure growth. From an entrepreneurial point of
view, Simmons et al (2009) state that entrepreneurship creates value through
innovation, seizing business opportunities. Similarly, Johnson (2001), who conducted
research on entrepreneurship and innovation, contends that entrepreneurship is the
conversion of ideas into marketable products or services.
Little research has been conducted about new service development in the health
service industry, with only a select number of notable works available: Duncan and
Breslin, 2009; Windrum and Garcia-Goni, 2008; Booz et al , 1982. Elsewhere,
Nambisan’s study (2002, p. 394) argues that in many different markets and situations,
customers are an excellent source of innovation (a view supported by Veryzer & de
Mozata, 2005). Tobin et al (2002, p. 93) also stress the importance of communication
and building a relationship with patients, stating: “the opportunities for consumer
participation occur first at this clinical interface in terms of what information is
transferred, in what direction, and in how the communication takes place. Nurturing
participation at this level has a fundamental role in consumer empowerment”.
Despite the importance of both entrepreneurship and customer-orientation in the
health care market, little has been written on either subject. The present study focuses
on the health services industry, examining both the demand for and provision of mental
health care in Greece. Within the structure of the health system in Greece, the private
health services sector includes Diagnostic Centres and Hospitals (general and obstetric
clinics), which are classed respectively in Primary and Secondary Health Care.
However, in recent years the industry has experienced great change following mergers
of organisations operating in the three wider sectors (general clinics, obstetrical &
-
8/21/2019 euromedica-mhs
2/373
2
gynaecological clinics, and diagnostic centres). This has resulted in the growth of health
care groups offering a full range of diagnostic and treatment services. As the market for
private health care has grown, so too has the competition between organisations, each
trying to offer better service quality, promptness, and facilities than one another.
As regards the mental health care sector, it becomes apparent that there is a
noteworthy improvement in the areas of decentralisation of mental health services
(Madianos et al , 1999b). Yet there is much still to be done in terms of quality and
delivery of mental health care services. What is more, the mental health service sector
is not very highly exploited. There are few private independent hospitals of this kind
across Greece, even though the public sector appears not to satisfy the needs of the
patients. Detailed information can be found in Chapter 2.2.4.
The organisation that is the focus of this study is a leading player in the area of
diagnosis, prevention, and hospital care in Greece. Euromedica Group is mainly
involved in the foundation, organisation, and operation of clinical and scientific centres,
equipped with high-technology appliances. The organisation’s facilities serve ten
prefectures in Greece, while it invests in its personnel through continuous and extensive
training of its employees. In 2008, Euromedica recognised an unfilled niche in the
market for health care, that of mental health services. Following extensive market
research into this area of the health care market, including the limited availability of
such treatments geographically, the organisation decided to invest in and develop their
own services in this area. Therefore, this research provides important managerial
implications for the top management team of the Euromedica Group, regarding its
overall operation and particularly its mental health care division. Specifically, the
results of this research work give a factual picture of mental health services provision
within the organisation, along with the techniques that should be adopted to develop
and implement customised or personalised offerings for customers. Such action should
offer substantial competitive advantages to the Euromedica Group as well as the
opportunity to expand its operations within the mental health sector.
1.2 Current State of Knowledge and Research Questions
The researcher reviewed the research context and theoretical background in order
to identify the knowledge gaps and critical problems in the Greek health care industry
and especially in the private sector. After reviewing these resources, the research
-
8/21/2019 euromedica-mhs
3/373
3
questions relating to these knowledge gaps and aiming to solve critical problems were
composed.
1.2.1 Overview of the Research Context
In private sector health services, providers operate large-size companies, well-organised and with extensive experience in the health sector, which in many cases
constitute powerful business groups. Moreover, in most cases, physicians, apart from
their role in providing medical care, participate actively in management as shareholders
in these companies.
The failure of the public sector, in conjunction with structural problems of the Greek
NHS, identifiable primarily as inadequate infrastructure, technological retardation, and
lack of medical-nursing personnel, is a very strong point for the industry in question.
The rise of living standards, the gradual ageing of the population, the emergence of new
diseases, and the increasing number of people covered by private insurance companies,
all contribute to the gradual increase in demand for private health services and
preventative medicine. Moreover, the evolution of medical science in conjunction with
the development of technology in the health sector, create growing demand for direct,
more efficient and higher quality health services.
Especially in recent years, large firms, as members of international organisations,
maintain partnerships with major medical institutions abroad, thus ensuring their
participation in various research projects. Finally, a strong point for the industry is
considered the ‘industrial peace’ in the private sector, as opposed to the public, where
the strikes of the medical-nursing staff are very common.
Competition is particularly fierce in the sector of private health services. The entry
of a new business into the industry of private health services, from the technical and
economical points of view, is therefore not an easy task. The obstacles to the creation
of new companies in the industry are placed by the current institutional framework. In
the case of hospitals, conditions and especially the construction specifications are
considered by stakeholders as particularly severe. At the same time, health services are
targeted to individual consumers, hence their, health service providers', bargaining
power is limited. However, the opinion of the doctor of a patient, always in combination
with that of the insurance company (if one exists) and of course, a good knowledge and
awareness of the market, may lead them to choose the most economically advantageous
solution in the context of their own needs and requirements. Finally, foreign markets,
-
8/21/2019 euromedica-mhs
4/373
4
particularly the countries of Eastern Europe and Turkey, which show significant
deficiencies in health infrastructure, have concentrated, especially in recent years, the
interest of investors of large business groups. The geographic imbalance of private
nursing units also creates growth opportunities beyond Athens and Thessaloniki, where
the largest number of them is currently concentrated. This is reinforced by the fact that
there is considerable room for improvement in the quality of health care in regions
outside of Athens and Thessaloniki. The extension of cooperation of private health
facilities with an increasing number of private insurance companies, as well as the
contracts with insurance funds, has resulted in broadening their customer base through
the coverage of medical expenses for a greater range of patients.
Moreover, the increasing number of migrants, whose economic profile does not
enable them to benefit from private health services, has led to congestion of public
hospitals, an element that turns a part of demand towards the private sector. In addition,
the proliferation of programmes through interest-free instalment payment is a reality
now in the field of private health, as is the “outpatient card”, which offers scalable
discounts for series of medical tests. Lastly, home care, provision of day nursing
services, tele-medicine, and robotic surgery, rehabilitation centres, nursing hostels and
geriatric clinics and stem cell banks are all areas that have significant growth potential
in Greece, while paediatric, gynaecological and oncology units, plastic surgery centres,
IVF centres, and even centres of natural health and wellness, concentrate the interest of
investors.
1.2.1.1 The Greek Health Care Market
Especially in recent years, the industry is characterised by significant changes due
to mergers and acquisitions between companies in three broad areas of activity (general
clinics, obstetric and gynaecological clinics, diagnostic centres). One result of this trend
is the prevalence of multi-purpose business groups for medical services, which offer a
full range of services for diagnosis and treatment. The competition between private
health units, has been particularly intense in recent years and focuses primarily on the
replacement of medical equipment; the range, quality enhancement and the speed of the
services provided; the extension of the network (presence in most areas); and
cooperation with insurance funds.
Furthermore, the total domestic market for private health services (in value) shows
longitudinal growth during the period of 1998-2008; its size was estimated in 2008 at
€1.985 million, compared to €574 million in 1998, representing average annual growth
-
8/21/2019 euromedica-mhs
5/373
5
rate 13.2%. In the area of private hospitals, the greatest market shares appear to be held,
for 2008, by Hygeia Group and IASO Group, followed by BIOMED and Euromedica.
1.2.1.2 Euromedica Group
Euromedica Group has 44 diagnostic centres covering all medical specialities; 18
general, obstetrics and gynaecology hospitals; 9 rehabilitation and recovery centres, as
well as one spa, health and cosmetic surgery centre, having a total capacity of 1621
beds. The Group's principal activities are the provision of health and wellness solutions,
all over Greece.
Euromedica Neurological Services is the leading provider of private mental health
treatment and associated care services in Greece, with a network of 3 acute hospitals
and care homes (Thermaikos, Castalia and Galini), which employ more than 350
people. The organisation offers a range of inpatient, outpatient, day patient and
residential treatment programmes, as well as therapy services that include condition
management programmes as well as psychological and psychiatric services, such as
secure and step-down services, complex care and rehabilitation services. It also
provides autism services and care of the elderly. It continues to establish new services
each year in partnership with government bodies.
1.2.2 Theoretical Background
The framework (Fig. 1.1) provides an overview of the main groups of literature
that formed the basis for this study. Four theoretical concepts were adopted and studied:
Theory of Service Innovation; Theory of Corporate Venturing; Theory of New
Service/Product Development; Theory of Customer Orientation. Each one is discussed
in detail and in relation to one another in the following sections of this research thesis.
Figure 1.1 Theoretical Framework of the Research
-
8/21/2019 euromedica-mhs
6/373
6
1.2.2.1 Corporate Venturing and Innovation
Many authors have highlighted the lack of research regarding the synergy between
innovation and entrepreneurship (e.g. Zhao, 2005a; McFadzean et al, 2005). In
particular, Zhao (2005a, p. 25) states, “the combination of entrepreneurship and
innovation holds the key to organisational sustainability.” He also argues (Zhao, 2005b)
that the synergy between the two concepts helps the organisation prosper and in
addition, reports (2005a, p. 28) that “innovation is the specific tool of entrepreneurship
by which entrepreneurs exploit change as an opportunity for a different business or
service”.
Another group of authors link innovation and entrepreneurship and draw similar
conclusions and postulations to Zhao (2005a) are McFadzean et al. (2005), who
produced models displaying their holistic definition of entrepreneurship and
innovation, and another displaying the attitudes, visions and actions necessitated,
according to the authors, to act as the linkages between innovation and corporate
entrepreneurship.
The responsibilities of the corporate entrepreneur are, according to various authors
(e.g. Barringer & Bluedorn, 1999; McFadzean et al, 2005; Thornberry, 2001; Guth &
Ginsberg, 1990), intrinsically linked to the task of innovation, and include tasks such
as locating and assessing new opportunities, managing resources and perhaps
challenging bureaucracy. Kelley (2011), who carried out research aiming to describe
how traditional companies can apply corporate entrepreneurship to their operations,
also links and draws parallels between, not only corporate entrepreneurship and
innovation, but also innovation and the ability to enhance an organisation’s competitive
positioning and to provide outstanding value for its customers. Another study
conducted by Zhao (2005a) suggests that innovation and entrepreneurship are dynamic
and holistic processes that are not restricted to the initial activity of a new undertaking.
This can be viewed in the light of De Burcharth and Ulhøi’s (2011) recent study; they
examine alternative organisational approaches to producing radical innovation and
report that such innovation usually derives from new business ventures.
However, Zhao (2005a) warns of the potential dangers of being a highly innovative
organisation, such as the lack of real measurability of the contributions of
entrepreneurship and/or innovation, or conversely, such successful innovation leading
to potential job losses (through improved technologies). Issues may also arise with
-
8/21/2019 euromedica-mhs
7/373
7
regard to managers potentially feeling that they are losing their control over an
organisation or department when they allow for increased creativity and freedom for
staff.
Some authors support the opinion that corporate venturing is a viable option only
for large organisations who are able to supply the expenditure realistically required to
succeed in this task (Gapp & Fisher, 2007; Zahra, 1996). However, corporate venturing
can prove an effective option for firms to gain knowledge and skills that will often lead
to future revenue streams (Greene et al, 1999). According to Tidd and Barnes (2000, p.
109), however, “many firms (in life sciences industries) have failed to differentiate
sufficiently between strategic, financial and operational goals, and have therefore
created inappropriate forms of corporate venture.” Therefore, one of the key objectives
of this research is to investigate the relationship between innovation and corporate
venturing within the health care industry.
1.2.2.2 New Service Development and Customer Orientation
Continuous service innovation has been described by many authors (e.g. Smith et
al, 2007; Tidd & Hull, 2003; Day & Wensley, 1988; Storey & Easingwood, 1999) as
the most valuable means for companies to achieve long-term success and organic
growth (Melton & Hartline, 2010). It is also suggested that for service firms to achieve
even greater success, a customer-orientation perspective should be adopted (Sing Wong
& Tong, 2012; Svendsen et al, 2011; Ottenbacher & Harrington, 2008). This position is
enhanced by Greer and Lei’s (2012, p. 63) recent study, which emphasises how
enterprises undertake collaborative innovation with individuals and business customers
and concludes, “Collaborative innovation with customers or users is increasingly
important for the development of new products and services.”
Rehme and Svensson (2011), combine entrepreneurship and marketing theories to
illustrate the approaches that new ventures employ to achieve key milestones. They (p.
6) clearly support the above viewpoint mentioning that “firms that involve customers
or users in their product development processes are more likely to succeed in the market
than firms that do not at an early stage receive feedback from users, and direct customer
involvement in the development of their offering is likely to increase revenues with a
guaranteed sale, making it necessary for them to have a strategic view on customer
involvement”. Similarly, Jenssen and Aasheim (2010) carried out research that analyses
the effects of organisational factors on innovation and performance in knowledge-
intensive businesses and argue that the success of product development depends on the
-
8/21/2019 euromedica-mhs
8/373
8
level of market contribution to the development process. Carbonell et al (2011)
reinforce this viewpoint, arguing that close customer participation increases service
advantage and speed to market, while lead-user contribution augments the novelty of
new offerings and service advantage even though this affects market performance
negatively.
When it comes to service development, Kandampully (2002, p. 19) states,
“innovation can be translated as a firm’s foresight to think for the customer by creating
services that drive the marketplace.” In a study looking at customers’ value in service
development, Jiménez-Zarco et al (2011, p. 57) state that “the value that consumers
provide derives from their use of services in day-to-day life, which makes their
experience and knowledge pertinent, particularly for increasing market acceptance of
new services, improving services, identifying market trends early and providing a
source of new ideas”.
However, consumer involvement is not without its challenges. Many authors share
the opinion that customers have a limited ability to provide valuable input into the
development process (e.g. Bonner & Walker, 2004; Christensen & Bower, 1996;
Edvardsson & Olsson, 1996). For instance, Hillebrand et al (2011) conducted a study
that aims to explore the differential effect of customer orientation and future market
focus on organisation inertia and firm innovativeness and conclude that firms become
passive and worn-out when they focus only on customers’ expectations. Likewise,
Edvardsson and Olsson (1996) note that firms should take into account the customers’
needs and wishes via an open dialogue, but they should not involve them directly in the
service development process. Taking this further, other researchers argue that the design
and the development of a new product should be carried out only by professionals
(Gales & Mansour-Cole, 1995; McQuarrie & McIntyre, 1986). Contrary to this view,
Magnusson (2003) argues that users provide more valuable and original ideas than do
professionals. However, despite such debate, customer involvement remains an
underdeveloped research area in the new service development process (Alam, 2002;
Alam & Perry, 2002; Johne & Storey, 1998), and, as discussed by Martin and Horne
(1995), direct customer participation is in any case of rare occurrence.
1.2.3 Knowledge Gaps and Research Questions
A number of studies concerning the service sectors and in particular service
innovation have been carried out, but they have rarely been conducted in the context of
-
8/21/2019 euromedica-mhs
9/373
9
health care and in particularly, in mental health care. In addition, few studies have
focused on the interaction and involvement of patients in the development of new health
services and even less in the design and development of new mental health services.
Lastly, there is no study that aims to investigate the growth and sustainability of a health
care organisation from two different perspectives, that of service innovation and how
can this lead to the exploitation of entrepreneurial opportunities, and, on the other hand,
the involvement of customers, aiming at the development of new services that could be
used as the tool for the above growth, leading the organisation to sustainable
development. The researcher reviewed the research context of the Greek health care as
well as the relevant literature in order to develop the research questions below.
The health care industry is one characterised by innovation (Bowers, 1987), with
hospitals often acting as leaders in innovation as new treatments and technologies in
this arena emerge daily. However, this rapid rate of change can often stifle organisations
who may not have the resources to keep up and will end up suffering from business
inertia (Rohrbeck & Gemünden, 2011). Other potential problems regarding innovation
in the health care can lie in the bureaucracy and other such problems often associated
with the industry (Duncan & Breslin, 2009; Bellou, 2010). Efforts to ameliorate
problems and issues such as these have been illustrated in research by various authors
(e.g. Nijssen et al , 2006; Menor & Roth, 2007; Cooper, 1988) who suggest a rigid,
systematic approach to new service development as being able to provide a more
effective approach to successful innovation. Additionally, several studies have pointed
out the importance and contribution of customers and of the market in general in
successful service innovation, underlining that the degree of novelty depends on
customer-producer interaction as well as on the creation of a new value system among
the business partners (market orientation) (e.g. Den Hertog et al, 2010; Agarwal &
Selen, 2009). In this context, the following research question aims to examine the role
of the customers in the organisation’s innovation strategy. This will allow the researcher
to see whether Euromedica is extrovert or introvert, and also to gain a deeper
understanding regarding how the Group values customer participation:
RQ1: What is the role of customer (and of the market) in the development of
health services in Euromedica Group?
-
8/21/2019 euromedica-mhs
10/373
10
Likewise, corporate entrepreneurship may be defined as an organisational
capability, which promotes entrepreneurial behaviour within organisations in order to
overcome internal barriers, challenge bureaucracy, and encourage innovation through
novel business schemes (Salvato et al , 2009; Echols & Neck, 1998; McFadzean et al ,
2005). It is a concept that is often associated with competitive success and is said to be
achieved through various methods. Similarly, Kraus and Rigtering (2010), who see
corporate entrepreneurship as a company philosophy, cite that corporate
entrepreneurship is a strategy that improves firms' innovative capability and raises
employee satisfaction. One component of corporate entrepreneurship in particular,
corporate venturing is characterised by the literature as a core concept in the strategic
planning of organisations to develop innovations and gain competitive advantages and,
therefore, achieve organisational sustainability and long-term growth (e.g. Korsgaard
& Anderson, 2011; Narayanan et al, 2008; Husted & Vintergaard, 2004). Similarly,
other studies have argued that corporate venturing acts as a tool to boost company’s
innovativeness, and employees appear to be a critical factor of both innovation and
business expansion (Antoncic & Hisrich, 2003; Lumpkin & Dess, 1996; Covin &
Slevin, 1991). Following those arguments, it adds up to the interest of the researcher to
explore the research question below in the mental health care context, where no similar
studies have examined the corporate venturing activity in the sector:
RQ2: How does Euromedica Group exploit innovation in services so as to engage
in corporate venturing?
Furthermore, new service development activities are of vital importance, as they
strengthen current business and create the potential for new business ventures
(Frambach et al , 2003; Igel & Islam, 2001). The necessity to develop new services is
of particular importance in the health care industry due to the nature of the services
provided. Smith et al (2007), who implemented five different models on the design and
development of new health care services, found that in order for a development process
for health services to be successful the service design should harmonise with the
organisation’s objectives and strategies and with the interests and expectations of the
key stakeholders (government, health board, etc.). Moreover, service design should
focus on users’ needs and involve both customers and a range of other stakeholders,such as front-line staff, managers, and so on, in the development process. This is
-
8/21/2019 euromedica-mhs
11/373
11
consistent with Bowers (1987), who found that both external and internal inputs are
needed for the development of new service concepts, which then should be evaluated
by both therapists and doctors and patients. Likewise, Windrum and Garcia-Goni
(2008) developed a framework for new health service development that involves, on
one hand policy makers, and service providers and on the other, firms and consumers.
They highlighted the competences of health professionals, and their interactions with
patients, mentioning that those determine service characteristics. Nevertheless, it
became clear in the review of the literature, and as it is shown in the subsections 4.2.2.3
and 4.2.2.4, in the past years, health care organisations used to focus more on the
expectations of their medical staff and third-party payers and less on their medical
consumers’ needs (e.g. Ford & Fottler, 2000). In addition, Charles et al (1997) indicate
clinicians as the ‘perfect agents’ for their patients, and other studies have shown that
there are still doctors and nurses who believe that mental health service users have not
much to contribute to decision-making and to new service development (e.g. Bennetts
et al, 2011). The above arguments lead to the question whether medical staff agrees
with the involvement of patients in such processes and what role would they play if the
management of a hospital decides to take action by asking customers (patients and
relatives) to contribute to its innovation activities. The following research question aims
to explore medical staff’s perceptions of customer orientation, as there is no clear
picture in the literature about their role in the development of patient-oriented services:
RQ3: What are medical staff’s perceptions of customer orientation and what role
do such perceptions play in the development of patient-oriented services?
It is also widely recognised that customer-oriented businesses improve customer
satisfaction and deliver better service quality (e.g. Kelley et al , 1990; Hartline et al ,
2000). This point is particularly relevant to the health care industry as health services
need to be modified for individual patients, balancing their medical needs so as to
increase efficiency (Berry & Mirabito, 2010). Furthermore, increased customer
orientation seems positively to influence medical scientists' working practices and their
sense of professional expertise (Cohen et al , 2004). Another important point is the
increased access to information regarding health care now available to customers. This
has led the current health care experience to move from simple procedures and services,
towards a holistic process that starts before admission and is completed after discharge
-
8/21/2019 euromedica-mhs
12/373
12
(Ford & Fottler, 2000). All this implies that executives must always consider effective
ways to provide health care services. Wood et al ’s (2000) study, suggests that health
care organisations should focus on new approaches, such as customer orientation, to
achieve patient satisfaction. Similarly, Lord (1989) concluded that the aims of involving
patients are generally to advance health outcomes, raise satisfaction, and/or reduce cost.
In recent years, users of psychiatric services have taken a more active role in their
treatment and hospitalisation. Research by Barnes and Wistow (1994) and Campbell
(2001) found that until the early 1980s, patients used to be passive recipients of their
treatment, having no participation in and little influence over the services they used.
Indeed, the World Health Organization (1990) advised that patients should be involved
in the decision-making process with regard to their treatment, yet it has been reported
in the literature that mental health patients have not been treated with equal
consideration as other types of patients (Lammers & Happell, 2003). Nevertheless,
many changes have occurred since the 1980s that have led to mental health patients
gaining increased influence over the services they receive, including users having
increased control of their care and the decisions involved, and better availability of
knowledge of the types of treatments delivered. This shows that patients are a critical
actor in service development, especially in mental health care environments. Therefore,
as many studies have noted, there is a gap in the literature regarding how mental patients
should participate in new service development (e.g. Ford & Fottler, 2000; Davies et al,
2009; Bennetts et al, 2011). The last research question below aims to address this gap:
RQ4: How should mental health service users be involved in the service
development process?
1.3 Overview of the Limitations of the Literature
As already mentioned, little research has been conducted studying the relationship
between innovation and entrepreneurship (McFadzean et al , 2005; Zhao, 2005a;
Littunen, 2000; Cornwall & Perlman, 1990; Zahra, 1995; Hornsby et al , 2002; Ireland
et al , 2001), with some researchers putting this down to definitional ambiguity
regarding both concepts (McFadzean et al , 2005; Hornsby, 2002; Morris et al , 1994).
In addition, customer involvement remains an underdeveloped research area in the new
service development process (Alam, 2002; Alam & Perry, 2002; Johne & Storey, 1998).
-
8/21/2019 euromedica-mhs
13/373
13
This research highlights the observation that, despite the health care industry's being
an excellent example of an industry with many opportunities for innovation and new
service development, it remains an underexplored area of research. This lack of
research is particularly apparent in the sector of mental health care, where customer
involvement in service development is of particular importance. Even though patients
are a critical actor in the service development process, users’ preferences and
competencies have not been widely explored. Moreover, the author has found that no
substantial research has been undertaken regarding entrepreneurship in the health care
industry. It would be useful to study how health care organisations choose to develop
new business ventures in order to deliver new service offerings.
1.4 Overview of the Conceptual Framework
This study follows a specific sequence of discussion that leads to the development
of its conceptual framework (see Chapter 5). The conceptual framework consists of
four key concepts, showing also the driving forces that push health care organisations
to innovate as well as the entrepreneurial and the new service opportunities that emerge
from the multiple combination of service innovation and corporate venturing and, on
the other hand, of new service development and customer orientation. Although these
key concepts have been derived from different disciplines and areas of research, it has
been essential to incorporate them into a study and also understand their influence in
the Greek health care industry. The rationale of integrating each of these key concepts
into the development of the conceptual framework is discussed in detail in Sections 5.4
and 5.5 in Chapter 5.
1.5 Contribution of this Thesis to the Area of Study
The results of this study could be advantageous to several parties. The following
table (Table 1.1) illustrates the contributions of this study, which were divided into two
parts based on their respective theoretical, practical and pedagogical functions (see also
chapter 12).
-
8/21/2019 euromedica-mhs
14/373
14
Table 1.1 Contributions of the Study
Contributions of the study Beneficiaries
Theoretical contribution Researchers in the fields of service
innovation and corporate entrepreneurship
Mental health care sector in Greece
Practical contribution
Conceptual framework
New business development model
Strategic team and hospital executives of the
Euromedica Group
Doctors and other medical staff of the
Euromedica Group
Theoretically, the present study undertakes a critical approach to innovation and
entrepreneurship opportunities in the mental health sector, reflecting on joint ventures,
dissemination of expertise and knowledge, delegation of initiatives to multiple agents,
power sharing and research evidence. Together with developing a conceptual model for
innovation in mental health services, the need for change in organisational culture and
the strategies for the growth of user initiatives are considered. Taking a case study
approach, the strategies adopted by the Euromedica Group for market expansion and
leadership are analysed and are then connected to the internal structure of the
organisation. Current and emerging opportunities for corporate growth are identified
by board members, shareholders, management staff, and healthcare professionals. The
contributions of each of these agents is determining for the entrepreneurial mission
statement of the company. It becomes evident in the data analysis that although the
company consists of a dynamic and creative management team capable of identifying
growth opportunities and venues. They also have exhibited a solid knowledge of the
idiosyncrasies of the local market and have adapted their corporate plans to meet local
and national needs. They are now in the process of forming strong partnerships with
public bodies, pursuing opportunities for radical innovation.
At the same time however, there is the question of the influence of organisational
culture on strategic decisions. Greek organisations are reported to follow in their vast
majority a top-down approach to management, which makes it unlikely for Euromedica
to endorse an inclusive approach to the user movement. It is interesting thus to
investigate the attitudes and perspectives at different layers of management and
authority within the organisation and link these with the organisational structure of the
company. Obstacles in the organisational culture are identified and a new concept ofinnovation is outlined to include opportunities for new kinds of partnerships, customer-
-
8/21/2019 euromedica-mhs
15/373
15
oriented services, and entrepreneurial growth. The argument for changing attitudes,
which will bring about more flexible and adaptable organisational structures and more
inclusive care services is formed.
This study reviews the relevant literature and develops a framework that
investigates and explores the level of patient involvement required for successful new
service development and how these new services could aid the organisation of new
establishment and growth in the sector of mental health hospitals. The purpose of this
study is, therefore, to investigate the influence of service user involvement on new
service development and how the outcome can enhance a firm’s entrepreneurial
activity, within the context of the health care market. This research responds to calls for
the further development and investigation of the concepts of customer participation in
the new service development process as well as of the link between innovation and
entrepreneurship (e.g. Jones & Rowley, 2011; Melton & Hartline, 2010; Alam & Perry,
2002; Matthing et al , 2004; Zhao, 2005a; Shaw et al , 2005). It also attempts to bring
the promising lens of entrepreneurship to the still emerging field of service innovation.
The main output of this study is the development of a conceptual framework within
which to examine how new service development contributes to corporate
entrepreneurship activities. More specifically, the conceptual framework devised in this
research contributes to the existing service development literature by providing
guidance on how to investigate the way health care organisations develop services that
meet the needs of their customers, whilst also identifying and capitalising upon
emergent entrepreneurial opportunities. This study also contributes to the discussion on
customer-oriented new service development. Customer participation in new service
development is a relatively new area of research, with few authors having discussed the
related benefits and potential issues. The current research work is the first to apply this
concept to the health care industry.
This study and the framework devised have highlighted the relationship and
interaction of innovation and entrepreneurship, and it is again the first of its kind to
apply this theory and discussion to the health care industry. Furthermore, it is found that
for organisations within this industry to be successful, they must adopt service
innovation strategies that will allow them the ability to identify entrepreneurial
opportunities. This framework represents a step forward in innovation and
entrepreneurship research as it provides a new insight into the identification of
-
8/21/2019 euromedica-mhs
16/373
16
entrepreneurial opportunities through customer-oriented new service development in a
more integrated and systematic way than has been previously implemented.
In practical terms, this research complements the strategic and operational
framework of the Euromedica Group. Managerial implications involve, firstly, the
adoption of such service development processes as will be well-designed, organised,
and coordinated in such a way as to promote quality and innovation in order to increase
the chances of success. Secondly, it emerges that Euromedica lacks an appropriate
business culture and organisational structure, as there is insufficient cooperation
between the health units and central offices. The company needs to attain an
entrepreneurial behaviour that would build on the existing organisation, improve the
internal business climate, and enhance efficiency. Thirdly, Euromedica should develop
an innovation plan, adopt processes, and exploit resources that would advance
innovation activities, augment entrepreneurial opportunities, and improve
competitiveness. Lastly, it appears that the company considers patients as a useful
source of service improvement with regard to the residential services provided, though
it has not adopted procedures to integrate them with the new health service development
process. Euromedica needs to incorporate service users in its development activities in
order to develop offerings that fulfil customers’ needs and wants. For this reason, it
should adopt approaches and develop processes that take customers’ opinions into
account, so facilitating the firm's provision of customised services.
1.6 Overview of the Research Methodology
Considering all the above, qualitative research was conducted, following the advice
of Rohrbeck and Gemünden (2011, p. 234), who state, “for research fields that are
relatively new and about which the knowledge is limited, a qualitative research design
is recommended.” The study was implemented in three research sections. Each section
stressed the issues to be addressed. The first included in-depth élite interviews with
higher executives of the Euromedica Group, as well as with the administrator of each
psychiatric hospital. The aim was to investigate issues relating to innovation,
entrepreneurship, and customer orientation from the standpoint of management. The
second section comprised semi-structured investigative interviews with selected
medical staff of each hospital in order to examine issues, from a medical point of view,
involving the participation of users in developing and delivering services. The third
-
8/21/2019 euromedica-mhs
17/373
17
section carried out semi-structured interviews with chosen patients from each hospital
to present the views and beliefs of mental patients about their own treatment and the
conditions under which they live. The main goal was the acquisition of a deeper
understanding of their positions and thereafter a comparison with the views of other
stakeholders.
Notwithstanding the fact that each section of the research is independent, together
they provide extensive and useful information from different angles. The information,
compared and combined, provides answers to important questions: how should patients
be involved in service development; what is the role of the client (and of the market) in
the development of health services in the Euromedica Group, and what is the opinion
of medical staff with respect to customer orientation, and what role do they play in
developing patient-oriented services? Therefore, the views of all kinds of stakeholders
are comprehensively appreciated, as regards the development of new customer-oriented
health care services and exploitation of business opportunities through corporate
investments. The interviews, in all the sections of the research, were conducted during
the period of December 2010 - March 2011.
Given that this research was carried out through semi-structured and exploratory
interviews, all sections of the research followed the same qualitative analysis process.
The main objective was to identify, investigate, and further compare the data collected
from all types of participants so as to achieve factual and constructive answers to the
research questions (Brown & Lloyd, 2001).
1.7 Overview of the Research Findings
1.7.1 Innovation Activity within Euromedica and its Mental Health
Hospitals
It is clear that senior executives of the Euromedica Group recognise the importance
both of the development of innovation and of entrepreneurial activity. Indeed, higher
executives identified many internal factors that stimulate innovation activity, such as:
the evolution of technology; the attitude of managerial and scientific staff towards
innovation; the evolving needs of patients; the quality of the service offerings; the need
to remain competitive and to have additional revenue from different sources in a time
of crisis. As an external factor that discourages firms from innovation, they identified
legislation, both financial and social. The management also claimed that tools are used
-
8/21/2019 euromedica-mhs
18/373
18
to identify customer needs and assess the health market, such as adequate information
systems, questionnaires, and so on, despite the fact that these have not yet been
established in their psychiatric clinics. Informal, rather than formal, processes of
developing new services have been adopted. Moreover, there is some disagreement
between management and scientific personnel on the rationale for and the establishment
of a culture where continuous improvement is to be considered as a rule. The former
maintain that there are on-going efforts to develop a business practice where everyone
will be enabled to take initiatives to improve service quality, satisfy customer
requirements and reduce operating costs, while the latter reported that such actions are
having no effect and that the firm is falling short of expectations.
Nevertheless, all participants agreed that the role of both senior executives and
medical staff is critical in adopting innovation and in enhancing the process of services
development. There is room for improvement, though, as there are gaps in staff
participation in decision-making and cooperation with management. Despite this, it has
been found that the company is not rigorous in condemning efforts that fail, but prefers
to acquire knowledge from experience. In any case, few people claimed that the
company has created a system where innovation thrives without restrictions; most
respondents stated that further measures should be implemented to enhance the
organisation's structure and achieve better results. Participants argued that the stimulus
of development encourages innovative activity and Euromedica has shown that its
business goal is to expand its activities in all sectors of the health sector, and beyond
national borders, as well as developing new services that meet the growing needs of
customers.
This last is particularly important, as management observed that customers together
with other stakeholders lead innovation efforts. Therefore, they have developed
services that meet the needs of patients and take into account their demands. However,
the management team claimed that patients are able to play a role in enhancing
residential services in hospitals and stressed that only some users of psychiatric services
are able to contribute to the development process. However, there were respondents
who stressed that in psychiatric settings, there is no culture and organisation such as to
cater for the desires of customers and their integration into the process of service
development.
-
8/21/2019 euromedica-mhs
19/373
19
1.7.2 Venturing Objectives and Entrepreneurial Activities of the
Euromedica Group
It becomes clear that Euromedica seeks to establish a well-organised network of
hospitals and health centres throughout the Balkans area, providing all kinds of healthcare services and meeting customer needs for high quality health care. More
specifically, the company aims to have a medical centre in each county (prefecture) and
an equivalent number in big cities. Moreover, one of their business objectives is to
develop a local network in each region, to include a general and obstetric clinic, a
psychiatric hospital, a physical rehabilitation centre, and an artificial kidney unit. This
network will form the basis for extending its activities to neighbouring countries.
As regards mental health, Euromedica Group plans to establish an association of
ten units and develop new structures for primary care. This has great value as the market
for primary care of mental health is quite underdeveloped and there is ample scope for
action. It also shows that Euromedica promotes business ideas that seem to take into
account both patient care and economic efficiency, encouraging investors/physicians to
own more than half of the shares in the new investment, increasing the financial
contribution where appropriate, and organising the new partnership, utilising their
knowledge and experience in the health sector.
1.7.3 New Service Development in Euromedica Neurological Services
Data show that Euromedica has developed in the last two years, inputting new
services, creating new departments and, collaborating with scientists to develop the
Group. In the field of mental health, it seems that two of the three psychiatric hospitals
have taken significant measures, through the upgrading of infrastructure and
enhancement of services or by developing new ones, in order better to meet needs and
improve their competitiveness. Furthermore, it appears that the company wishes to
expand its activities in the field of mental health by adopting new practices; establishing
new structures that will contribute to the treatment of patients and enhance
deinstitutionalisation, and utilising the knowledge and expertise of scientists to benefit
both society and its position in the market place. As regards the operation of the
hospitals, the plan is the expansion of services, aiming to gain more customers.
Overall, it appears that ideas for development mainly come from staff, the
competition, and the evolution of science; fewer are drawn from from customers and
-
8/21/2019 euromedica-mhs
20/373
20
market research. It also appears that the coordination between departments in
developing new services is in need of improvement.
1.7.4 Customer Orientation and Health Services within Euromedica and
Its Mental Health HospitalsGenerally, it appears that Euromedica assesses the market, utilising a variety of
tools, such as statistics, reports, market research, observation of the competition,
cooperation with doctors, etc. Particularly in mental health, the company wishes to
collect information about: the demographic and social characteristics and the quantity
of potential customers; the socio-economic background; the status of the competition;
the cost of potential investments; economic benefits; and adequacy of the scientific
staff. Furthermore, Euromedica aims to establish solid relationships with doctors rather
than with customers. However, the customer viewpoint on services is taken seriously,
as special teams were formed within hospitals to improve services and increase
customer satisfaction. Moreover, despite all the shortcomings, the company is trying to
adopt techniques to monitor queries and complaints and to create mechanisms that
would integrate patients into the design of new services and lead to initiatives for
development.
Nevertheless, it is worth noting that although there is no great flexibility in adapting
the services already provided, many people support the involvement of patients in the
development of new services. Specifically, in mental health services it is evident that
hospitals make efforts to build a trusting relationship with customers by providing high
quality health care, arranging repeated sessions with psychiatrists and other doctors,
and maintaining constant communication with both patients and relatives. Still, it is
obvious that none of the hospitals uses specific tools to assess customer satisfaction or
respond to customer questions.
1.7.5 Patients and New Service Development in Euromedica Neurological
Services
First, it is important to note that the majority of patients surveyed preferred not to
be hospitalised, and seemed not to accept their psychiatric health ‘issue’. Few were
those who understood the need for help and even fewer were those who had decided on
hospitalisation. Nevertheless, respondents showed confidence in medical staff, noting
that they get comprehensive answers and feel safe in communicating their concerns and
fears. Only some have questioned the ability of physicians to provide appropriate
-
8/21/2019 euromedica-mhs
21/373
21
treatment and indicated that they prefer to manage their concerns without assistance.
Moreover, many patients have confirmed the sufficient number of nursing staff and
noted that are satisfied with the overall service, indicating though that there is room for
improvement in the diet. In addition, participants argued that the behaviour of staff is
appropriate; they therefore feel comfortable discussing a personal matter or sharing
their thoughts. Respondents were positive about the facilities of the hospitals, namely
the condition of the buildings, environment, amenities, etc. There were some, however,
who indicated that further improvements should take place.
Beyond that, participants said that they enjoy participating in activities, as these
strengthen their treatment and help them overcome their health difficulties. Moreover,
it is revealed that a large number of stakeholders were willing to participate in decision-
making regarding their health care. They recognised that this would be extremely
beneficial for the development of treatment and so for their psychological condition.
Only some argued the opposite. Still, it is noteworthy that in two hospitals, patients had
not so far been invited to comment on the services provided.
Nevertheless, many respondents argued that it would be exciting to join a
programme in which they could express their beliefs and perceptions about treatment,
so they are willing to contribute further to improving services. Furthermore, they agreed
that they should be employed to work in the hospitals, as this would be beneficial to
their health and would make them feel useful and creative.
1.8 Research Structure
Overall, this study comprises twelve chapters, which are briefly described below.
Fig. 1.2 illustrates the structure of the research.
-
8/21/2019 euromedica-mhs
22/373
22
Figure 1.2 Structure of the research
The second chapter focuses on the health care market, considering both demand and
provision. In particular, it encompasses general information on the Greek health care
industry, such as the structure of health services in Greece, the characteristics of the
industry, health expenditure, and an overview of the mental health care system of
Greece. With regard to the demand and provision of private health services, this chapterincludes the characteristics of and the factors affecting the demand for private health
services, as well as the development of its infrastructure and industry structure; the
conditions of competition, and a presentation of the private health care corporations. In
addition, the chapter describes the private health care market in Greece in terms of
domestic market size and the market shares of the health care groups. Finally, it gives
a profile of the Euromedica Group and Euromedica Neurological Services.
The third chapter reviews the literature and theories of service innovation,
entrepreneurship, and corporate venturing. Specifically, it defines service innovation,
Chapter 1
Introduction
Chapter 9 Chapter 10
Analysis of
Thermaikos Hospital
Analysis of
Castalia Hospital
Analysis of
Galini Hospital
Chapter 7
Analysis of
Senior Executives
Chapter 8
Chapter 2 Chapter 3 Chapter 4
New Service Development
& Customer Orientation
Research
Context
Service Innovation &
Corporate Entrepreneurship
Chapter 5Conceptual
Framework
Chapter 6Research
Methodology
Chapter 11
Review of
Key Findings
Chapter 12Conclusions
Chapter 1
Introduction
Chapter 9 Chapter 10
Analysis of
Thermaikos Hospital
Analysis of
Castalia Hospital
Analysis of
Galini Hospital
Chapter 7
Analysis of
Senior Executives
Chapter 8
Chapter 2 Chapter 3 Chapter 4
New Service Development
& Customer Orientation
Research
Context
Service Innovation &
Corporate Entrepreneurship
Chapter 5Conceptual
Framework
Chapter 6Research
Methodology
Chapter 11
Review of
Key Findings
Chapter 12Conclusions
-
8/21/2019 euromedica-mhs
23/373
23
highlights the importance of service innovation strategies, and identifies related
processes. Further, it focuses on entrepreneurship and its types and portrays the
dimensions and characteristics of corporate venturing.
The fourth chapter reviews the literature and theories of both new service
development and customer orientation. It defines new service development and
presents the types of, characteristics of, and critical factors for new service
development. It also illustrates the strategies and the processes of new service
development, with an emphasis on models for health service innovation. The chapter
also defines customer orientation, underlining customer roles in service innovation and
customer involvement in the health care industry. Lastly, it points up the processes for
customer orientation development.
The fifth chapter combines the theories of both corporate venturing and innovation
and customer involvement in new service development. It stresses the relation between
corporate venturing and service innovation and illustrates the models that combine the
two terms, or conceptualisations. It also draws attention to the importance of customer
participation in new service development activities. Finally, it develops the conceptual
framework for new service development through corporate venturing in health care,
applying the theories from chapters 3 and 4.
The sixth chapter discusses the methodology of the present research. It clarifies the
rationale for preferring qualitative research methods and describes the process of the
primary research. As noted earlier, there are three research sections in this chapter:
corporate and hospital; medical staff; patient-related research. These comprise the
totality of the research. Each section consists of:
the research objectives and questions;
data collection methods;
survey instruments;
samples;
data analyses; and
limitations of the research methods applied.
The seventh chapter is introductory to the analysis section of this research. It
examines the results of the élite in-depth interviews completed by top executives -
members of the decision-making team - of the Euromedica Group. The aims of this
chapter are to present the innovative activity of the Group in general, the tools and the
-
8/21/2019 euromedica-mhs
24/373
24
processes employed to develop new health services, the entrepreneurial model used by
Euromedica to expand its operations, and the strategy followed on customer
involvement in developing new offerings.
Chapters Eight to Ten investigate the operation of three mental health hospitals,
case-by-case. Each chapter falls into two parts. The first examines the views of both
administrative and medical staff regarding the factors that determine innovative
activity; the tools and the processes applied for new service development; the
contribution of customers and the role of executives and medical personnel into the
innovation process and the customer involvement in new health service development.
The second part explores the perspective of patients regarding hospital’s operation and
infrastructure along with their enthusiasm to be a part of the service development
process.
The eleventh chapter summarises the key findings of three sections of the research
and includes a cross-case synthesis. The twelfth and concluding chapter evaluates the
research findings and considers the contribution of this research to the field of study. In
particular, it relates the innovation and corporate venturing literature to theories
concerning new service development and customer orientation, resulting in the
development of a distinct conceptual framework. Implications of the findings at firm
level are also discussed, to suggest future research directions. The limitations of this
research are also discussed.
-
8/21/2019 euromedica-mhs
25/373
25
Chapter II
Research Context: Overview and Development of the Private
Health Care Industry in Greece
2.1 Introduction
The introduction of the National Health System (NHS) in 1983 set the basis for the
provision and distribution of both public and private health services in Greece. The
objective of this chapter is to explore the Greek private health services market and more
specifically, the sector of mental health, including addictions (substance abuserehabilitation). The chapter also includes the general characteristics of the industry, the
factors that affect the demand for private health services, and the supply of health
services by private health groups. The size of the health services market is presented,
with the market shares of the leading groups. The Euromedica Group's company profile
is presented, as well as the prospects of the Greek health care industry.
2.2 Overview of the Greek Health Care Industry2.2.1 The Structure of Health Services in Greece
The structure of the Greek health care system in the basic levels of health care is
as follows (W.H.O., 1996) (Fig. 2.1):
Primary Health Care: is also called outpatient care and covers services
concerning the prevention and diagnosis without requiring the patient to stay in
hospital. This level of care is covered by:
Public health centres, hospital outpatient departments and insurancefunds;
Doctors; professionals in their private surgeries;
Microbiological Laboratories;
Diagnostic Centres;
Private outpatient clinics.
Secondary and Tertiary Health Care: This refers to services for patients who are
hospitalised in hospitals or clinics as offered by: a) 144 public hospitals of the NHS and outside the NHS (military, S.I.I.) and 196 private hospitals (Health
-
8/21/2019 euromedica-mhs
26/373
26
Units Company data, 2004).
Emergency Medical Care: This is provided nationwide by the National Centre
for Emergency Aid (Ambulance Service).
Psychiatric Care: Apart from the psychiatric hospitals in the public and private
sectors, mental health care is also supported by the psychiatric departments of
general hospitals and a network of outpatient and community structures in the
public sector.
Table 2.1 shows the number of hospital beds per 1,000 habitants accounted for in
the censuses 1991 and 2001 by geographic region. According to the figures in the table,
some improvement is noted for the regions of Epirus, Thessaly, Thrace, Crete, and
Central Greece.
Fig. 2.1 Organisational Chart of Health Care System (source: W.H.O., 1996)
Government
Ministry of Labour
& Social Insurance
Deputy Ministry of
Social Insurance
Social Insurance Funds
Social Insurance Institute
(S.I.I.) urban polyclinics
Ministry of Health
& Welfare
Under-Secretary
of Welfare
Social Services
Direct Health
Directorates
Under-Secretary
of Health
General Directorate
of Public Health
Private HospitalsRegional Hospitals
District Hospitals
Health Centres
Rural Clinics
Central Health
Council
Government
Ministry of Labour
& Social Insurance
Deputy Ministry of
Social Insurance
Social Insurance Funds
Social Insurance Institute
(S.I.I.) urban polyclinics
Ministry of Health
& Welfare
Under-Secretary
of Welfare
Social Services
Direct Health
Directorates
Under-Secretary
of Health
General Directorate
of Public Health
Private HospitalsRegional Hospitals
District Hospitals
Health Centres
Rural Clinics
Central Health
Council
-
8/21/2019 euromedica-mhs
27/373
27
Table 2.1 Complement Indicator of Hospital Beds (1991 & 2001)
Region 1991 2001
Aegean
Islands5.0 4.1
Greater
Athens7.0 6.1
Epirus 3.7 4.3
Thessaly 3.2 4.0
Thrace 2.5 2.8
Ionian Islands 4.9 4.5
Crete 4.8 5.0
Macedonia 5.1 5.0
Peloponnese 3.0 3.0
Central
Greece1.9 2.6
Total 5.0 4.8
Number of beds per 1000 habitants
Source: Hospitals, N.S.S.G.
2.2.2 General Characteristics of the Industry
According to the World Health Organisation (1996), the majority of private
hospitals for secondary care operating in Greece are classified among those whose
capacity is from 41 to 100 beds, and there are also private hospitals which offer from
100 to 300 beds. Depending on their size, private general hospitals are divided into the
following categories: Large multi-clinics, which are located in Athens and Thessaloniki, and are few
in number. These clinics exceed 300 beds and the majority of them are staffed
by highly trained and skilled medical staff, deploying high-tech medical
equipment. They maintain agreements with insurers and public insurance funds,
and with most insurance companies in the private sector. These clinics cover a
wide range of services, including prevention and diagnosis.
Medium-sized clinics, which also usually maintain contracts with private
insurance companies and the public funds.
Small clinics, most of which cover the cost of hospitalisation of their patients
(in whole or part) via contracts with various public insurance agencies.
Neuropsychiatric clinics, which are a separate category, are sufficient in number
and their revenues come entirely from internal patients, with a high average
annual occupancy.
As for the geographical distribution of private clinics, the majority are around the
region of Greater Athens, followed by the region of Thessaloniki. In recent years, there
-
8/21/2019 euromedica-mhs
28/373
28
have been transformations in the private hospital sector, since small regional units have
consolidated with larger ones. Furthermore, in some cases, large units in the industry
became international by expanding their operations in foreign countries. An example is
the Athens Medical Centre, which has expanded its activities in various countries of the
Balkan area. The difficulty of the smaller units in responding to the rapid development
of medical technology and also the high cost of construction and equipment for new
treatment units are the two main reasons for the strategic acquisitions - mergers –
consolidation of the smaller firms.
2.2.3 The Mental Health Care System in Greece: An Overview
Traditionally, Greece’s mental health care system constituted of a network of state
psychiatric hospitals where patients were institutionalised. The development of this
system occurred during the 19th and the 20th century, when "asylum" units were
established. In 1832, Greece had no specialised care units for mentally ill people, who
received only informal treatment from their families or the church (Ploumpidis, 1989).
The first mental health care institutions were founded on Corfu by the British, who
handed the island over to Greece in 1864. Corfu’s hospital initiated biomedical
psychiatry and was the paradigm for future infirmaries (Blue, 1993). The Dromokaition
was established in Greater Athens in 1887, while at the beginning of the 20th century a
network of mental institutions were developed in Crete, Thessaloniki, and Athens. At
the end of the Greek Civil War (1946 – 1949), five psychiatric institutions composed
the central part of Greece’s inpatient mental health care. By the late 1950s, the rise of
private clinics and facilities was noted in Athens, Thessaloniki, and other large regional
cities (Ploumpidis, 1989).
Nevertheless, as Blue (1993, p. 306, 308) states, “the Greek government has
reinforced the prominence of the large mental hospital in the Greek psychiatric care
system through limited financial support for services, the absence of a national mental
health policy, and psychiatric legislation and (…) it has been minimally involved at
economic and policy levels in the creation of psychiatric care services other than mental
hospitals”. This is in conformity with Madianos et al (1999b, p. 170), who note that
“centralization of psychiatric care with an absence of community mental health services
and of psychiatric beds in general hospitals; (2) uneven regional distribution of services
in the country, leaving some regions without access to psychiatric care, and (3)
-
8/21/2019 euromedica-mhs
29/373
29
inefficient management of resources and lack of qualified administrative staff (…) was
totally inadequate to meet the psychiatric morbidity needs of the population”.
According to Stefanis et al (1986), Greek mental health transformation was
initiated in 1984 using funds from the European Community. That reform included the
development of new structures, such as mental health prevention services at community
level and psychiatric departments in general hospitals; the reduction of resident
psychiatric patients through the development of alternative modes of care, and the
improvement of service quality and living conditions through the training of mental
health personnel (Madianos et al , 1999b). At the same time, most mental patients start
their treatment in a private setting. Estimates show that more than 80% of those
hospitalised in a state hospital had formerly been in a private clinic (Blue, 1993).
Furthermore, Greek psychiatry has not assisted in the development of proper treatment
and settings over time as it mirrored, until recently, the notion that institutionalisation
is the appropriate handling for the ill.
However, there were some efforts in the past, by Greek governments with the
cooperation of experienced academics, to introduce new methods to enhance service
quality and delivery. A day hospital was launched in Athens with a 24-hour emergency
system (Mantonakis, 1981), two community mental-health centres were established, in
Athens and in Thessaloniki (Madianos, 1983; Manos & Logothetis, 1983); psychiatric
departments in general hospitals were developed across the country and long- and short-
stay homes have been set up to assist in deinstitutionalization (Blue, 1993).
More recently, a national programme, named ‘Psychargos’, was initiated in order
to improve the quality and specialisation of services provided to patients (Madianos et
al , 1999a). The first phase of the programme was executed in 2000 – 2001, where each
prefecture of the country houses a psychiatric facility, with Athens and Thessaloniki
having more than one (Bellali & Kalafati, 2006). More specifically, this phase should
introduce new organisations for community-based care, such as: half-way houses;
nursing homes and outpatient units; upgrading of public hospitals’ facilities; operation
of novel intervention and community after-care schemes, such as vocational workshops
to train patients; and training programmes in psychosocial rehabilitation for mental
health personnel (Grove et al . 2002). The second phase of this programme has been
running since 2002 until today and includes more initiatives, including:
Integrated psychiatric and paediatric psychiatry clinics in general hospitals,
including short-term inpatient units and a crisis intervention centre;
-
8/21/2019 euromedica-mhs
30/373
30
Day care centres for adults, adolescents and children;
Customised psychiatric services to the target group;
Ambulatory mental health units in areas with particular problems of access such
as islands and mountainous regions; Mental health community centres for adults and child guidance centres for
children and adolescents;
Counselling services to meet the needs of families caring for the mentally ill
(Grove et al . 2002, Madianos 2002).
‘ Psychiatric Reform’ in Greece
‘Unfulfilled reform’, ‘incomplete effort’, ‘neglected priority’ are some of the
characterisations attributed to or associated with Greek psychiatric reform, which has
already been in progress for two decades, but has not matched the hopes of those who
believed in a change in how to tackle mental health problems. Even the question of
funding, despite its undoubted importance, is only one side of a multifaceted problem,
the solution of which requires serious administrative and institutional interventions.
From an evaluation of progress so far, it can safely be said that psychiatric reform has
not been established in Greece and has not eliminated the asymmetries and inequalities
in the provision of mental health (Sakellis, 2009). Although it should not be overlooked
that progress has been made (such as structures in the community, transformation of
psychiatric hospitals, etc.), the following issues remain:
a system of service quality assessment on the part of public entities and private
legal entities, profit and non-profit,
connection of the funding of the mental health structures with the findings of
the evaluation,
updating public policy on Mental Health in order to delineate the objectives of
the state and the actions of bodies,
updating and completing the legal framework, taking into account the White
Paper of the European Union and the perceptions of both the World Health
Organization and the World Association for Psychosocial Rehabilitation,
a decisive role for the Sectoral Committees of Mental Health, maintaining their
operation and promoting service networking in each area,
staffing of all bodies and
consistent and adequate funding of all actions to ensure continuity of care.
-
8/21/2019 euromedica-mhs
31/373
31
Furthermore, the following issues were revealed from the interactions and the
positions developed in a conference entitled ‘The child with mental health problems:
The right to psychosocial rehabilitation", organised by the Greek Ombudsman (5 th
February 2009):
lack of facilities for young people in need of urgent treatment (child and
adolescent psychiatry),
lack of structures for psychosocial rehabilitation of children and adolescents
with mental health disorders or other serious problems that require medical
rehabilitation,
serious malfunction of private non-profit bodies and delays due to reductions in
funding.Resolving these issues is crucial to improve the quality of care for people with
mental health problems and to provide greater protection of their rights. However, no
policy on mental health can be successful if not accompanied by measures that combat
the stigma of mental illness and social prejudices. At the same time, it is necessary to
develop a support system for those families that have a mentally ill member
(Stylianidis, 2009).
Psychiatric reform regards the safeguarding the rights of people with mental health
issues and the role this can play both as a philosophy for the modernisation of services
that are focused on the asylum, and as a model for launching relevant procedures across
the Balkan region (Henderson, 2009). Although the value of psychiatric reform is
recognised, its evolution so far has proven incomplete. This emerged from the
conference ‘Psychiatric Reform in Greece: Requirements, recommendations and
solutions’, organised by the Greek Ombudsman in March 2009 (Sakellis, 2009). It was
also highlighted that:
1) Psychiatric reform is not well established in Greece. It was emphasised at the
conference that there lacks a movement which would focus on the cooperation of
workers in mental health care with patients and their families. It is worth noting that
individual initiatives cover the absence of a comprehensive state response of
institutional shortcomings and problems.
2) Current progress in mental health reform was rated as ‘ perverse’ because:
-
8/21/2019 euromedica-mhs
32/373
32
i. the reduction of psychiatric beds combined with the lack of alternative
community services resulted in dozens of makeshift beds in psychiatric
hospitals and psychiatric clinics in general hospitals
ii.
it has not yet achieved the desired ideological and institutional change thatwill lead to the disappearance of the concept and practice of detention and
other restrictive methods,
iii.
the power relations with patients have not been reshaped in such a way as
to transform them into subjects of change,
iv. the rationale and practice of the inpatient bed, either for housing or for
treatment, continues to dominate at the expense of support and alternatives
to ‘the asylum’.
3) The absence of longstanding and precise planning and the lack of guidelines on key
issues were identified in official mental health policy. In addition, the parallel
existence of the immunity system and care services in the community is regarded
as problematic, while the lack of prevention, the inadequate accessibility to health
services and the poor quality of care were reported as ‘chasms in mental health’.
4) The issue of ‘segmenting’ mental health services is regarded as important. Both the
rudimentary network of outpatient services with inpatient units and the inadequate
horizontal communication between the outpatient services cause major difficulties.
5) Mental health of children and adolescents is assessed as a neglected priority. In
particular, many in the conference noted that:
i.
research funding is inadequate in Child Psychiatry and this is not a subject
in education,
ii. there is a shortfall in relevant structures for mental health care in Greece.
Overall, from the 400 units that were provided under the scheme
‘Psychargos’, only ten are for children and adolescents. What is more, the
65 mental health facilities for children and adolescents set up in the last 25
years are unevenly distributed and so do not provide coverage for the entire
country,
iii. the existing structures are understaffed or barely functioning due to limited
funding. There is also a shortage of inpatient hospital units (40 beds in
Athens and Thessaloniki), while there is a lagging behind in developing
-
8/21/2019 euromedica-mhs
33/373
33
new structures as well as structures for day care (e.g. for young people with
autism),
iv. there are no organised and well-coordinated prevention programmes.
It must be understood that every action that delays Psychiatric Reform does notharm simply the mentally ill and their families, but works against the entire project of
reform in the area of social solidarity and acts against the people, social action, and the
richness of diversity in social aggregation (P. Giannoulatos, personal communication,
March 9, 2011).
2.3 Doctor and Patient: Is it a Relationship were the Doctor is the
Provider and the Patient is the Consumer or Vice Versa?2.3.1 Parsons’ Perception of Doctor-Patient Relationship
Parsons’ (1951) perception of the relationship between the doctor and the patient
is claimed to be an ‘ideal type’ model, which abstracts and presents what are considered
to be the fundamental features of a particular social organisation or social role, as well
as is an valuable method of analysing and describing very complex social phenomena.
Parsons depicted four general expectations that are entailed to the role of sick people;
as sick people are allowed, and might even be required, to give up some of their normalactivities and responsibilities, such as going to work or getting involved in physical
exercise, and additionally, they are regarded as being in need of care. The above two
expectations and privileges are, however, contingent on the sick person fulfilling the
third and the fourth obligations of wanting to get well as quickly as possible, and of
seeking professional medical advice and, most importantly for the doctor – patient
relationship, cooperating with the doctor, respectively.
Parsons highlights that the specific expectations of the sick person, as for example
the number and type of activities the person is expected to give up, will be influenced
by the nature and severity of the condition, since it is recognized that not all illness
requires people to abandon their normal social roles and occupy the status ‘sick’. For
instance, minor illness can be managed without recourse to the doctor and does not
involve any changes to a person’s everyday life. Correspondingly, people with a chronic
illness may have the need to consult the doctor regularly; however rather than
occupying a permanent sick role, they are usually expected to try to achieve their
maximum level of functioning and to acquire the status ‘sick’ only in cases of a change
-
8/21/2019 euromedica-mhs
34/373
34
in their usual health. Consequently, it is obvious that Parsons viewed the role of the
patient as a temporary social role that has been instituted by society, which aims to
return sick people to a state of health and restore them to fully functioning members of
it as quickly as possible. Finally the role of the patient is also considered to be a
universal role which has its obligations and expectations that apply to all sick people,
regardless their age, gender, ethnicity, occupation or status in other spheres.
On the other hand, the role of the doctor is viewed as complementary to the role of
the patient. As the patient is expected to cooperate fully with the doctor, doctors are
expected to apply their specialist knowledge and skills for the benefit of the patient, as
well as to act for the welfare of the patient and community rather than in their own self-
interest. Doctors are also supposed to be objective and emotionally detached, and also
to be guided by the rules of professional practice, as the conformity with these general
expectations is a vital requirement in order to carry out the tasks of diagnosis and
treatment, and most importantly when this process involves the need to know.
2.3.2. New Terminology
As mentioned earlier, Parsons’ theory of both the roles of the patient and the doctor
is the ideal one and does not apply in reality, where, on the contrary, doctors are
considered as the providers while the patients are regarded as customers. According to
Hartzband and Groopman (2009), the root of this new vocabulary is a result of both the
industrialisation and standardisation of medical care in order to achieve cost control.
The relationships between doctors, nurses, or any other professional in the field of
medical care and the patients are determined mainly in terms of a commercial
transaction, as the consumer or customer is the buyer and the provider is the vendor or
seller, because of the financial aspect of the clinical care. However, it is claimed that
this is only a small part of a much larger whole, and to patients, it is the least important
part. There has been a lot of debate concerning the relationship between the medical
care professionals and their patients, and its commercialisation. Most of them are with
regard to high-deductible health policies and budget plans for clinical care that assume